학술논문
HLA-mismatched donor lymphocyte infusion is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allogeneic stem cell transplantation
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
02683369